Xense
Meta CT, FIRST In The World. Minimize Time to Diagnosis, Treatment & Wellness
Analytics
Raised: $121,739
Aggregate Commitments $
Wefunder
06/14/2022
04/30/2023
$150,000
$1,070,000
$500
SAFE
RegCF
Series B
$228,000,000
20%
Rolling Commitments $
Active
06/25/2022
309
81%
11%
$11,067
Irvine, Delaware
Healthcare & Pharmaceuticals
HealthTech
B2B
Medium
High
Summary Profit and Loss Statement
Most Recent Year | Prior Year | |
---|---|---|
Revenue |
$5 |
$0 |
COGS |
$15,466 |
$0 |
Tax |
$2,588 |
$0 |
| ||
| ||
Net Income |
$-988,204 |
$-1,021,526 |
Summary Balance Sheet
Most Recent Year | Prior Year | |
---|---|---|
Cash |
$13,752 |
$63 |
Accounts Receivable |
$0 |
$0 |
Total Assets |
$292,218 |
$122,030 |
Short-Term Debt |
$520,086 |
$157,043 |
Long-Term Debt |
$861,936 |
$531,943 |
Total Liabilities |
$1,382,022 |
$688,986 |
Upgrade to gain access
-
$12.42 /month
billed annually - Free portfolio tracking and KingsCrowd's quantitative ratings on all raises.
- Plan Includes:
- Everything in Free, plus
- Company specific
KingsCrowd ratings (excluding risk)
- Advanced company search ( with ratings)
- Markets page filters and historical industry data
- Get Edge Annual
Edge
-
$41.58 /month
billed annually - Full site access including KingsCrowd's qualitative analyst reports.
- Plan Includes:
- Everything in Edge, plus
- Full access to detailed Analyst Reports (e.g. Top Deal, Deal to Watch, Neutral, and Underweight)
- Search and filter based on Analyst Reports
- In-depth risk ratings for every raise
- Get Edge Pro Annual